Analysts who follow Silverback Therapeutics Inc (SBTX) on average expect it to fall -42.15% over the next twelve months. Those same analysts give the stock an average rating of Hold. That average rating earns Silverback Therapeutics Inc an Analyst Ranking of 5, which means it ranks higher than 5 of stocks, based on data compiled by InvestorsObserver.
Wall Street analysts are rating SBTX a Hold today. Find out what this means to you and get the rest of the rankings on SBTX!